Carr Daniel B 4
4 · JAVELIN PHARMACEUTICALS, INC · Filed Mar 29, 2010
Insider Transaction Report
Form 4
Carr Daniel B
DirectorSee Remarks
Transactions
- Exercise/Conversion
Stock Option
2010-03-25−5,307→ 90,593 totalExercise: $1.07Exp: 2019-01-23→ Common Stock (5,307 underlying) - Exercise/Conversion
Stock Option
2010-03-26−767→ 89,826 totalExercise: $1.07Exp: 2019-01-23→ Common Stock (767 underlying) - Exercise/Conversion
Common Stock
2010-03-26$1.07/sh+767$821→ 156,668 total - Sale
Common Stock
2010-03-26$1.35/sh−700$945→ 155,968 total - Exercise/Conversion
Common Stock
2010-03-25$1.07/sh+5,307$5,678→ 160,601 total - Sale
Common Stock
2010-03-25$1.35/sh−4,700$6,345→ 155,901 total
Footnotes (3)
- [F1]Includes (i) 31,246 shares of common stock, (ii) 5,000 shares of common stock purchased pursuant to the Issuer's Employee Stock Purchase Plan and (iii) 119,048 Deferred Stock Units (DSUs) granted on May 1, 2009.
- [F2]Granted under the Issuer's Amended and Restated 2005 Stock Incentive Plan.
- [F3]Vesting in three equal annual installments beginning after the first year.